Free Trial

Applied Therapeutics (APLT) SEC Filings & 10K Form

Applied Therapeutics logo
$0.39 +0.02 (+6.49%)
As of 03:51 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Applied Therapeutics SEC Filings

DateFilerForm TypeView
03/31/2025
6:00 AM
Applied Therapeutics (Filer)
Form NT 10-K
03/26/2025
7:25 PM
Applied Therapeutics (Issuer)
Hooks Corwin Dale (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
7:14 PM
Applied Therapeutics (Issuer)
Chinoporos Constantine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
7:21 PM
Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
7:30 PM
Applied Therapeutics (Issuer)
Chinoporos Constantine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
7:30 PM
Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
7:30 PM
Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:11 PM
Applied Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
3:30 PM
Alyeska Investment Group, L.P. (Filed by)
Applied Therapeutics (Subject)
Form SCHEDULE 13G
02/14/2025
3:15 PM
Applied Therapeutics (Subject)
Schonfeld Strategic Advisors LLC (Filed by)
Form SCHEDULE 13G
02/14/2025
1:35 PM
Applied Therapeutics (Subject)
Vestal Point Capital, LP (Filed by)
Form SCHEDULE 13G
02/14/2025
10:36 AM
Applied Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
02/07/2025
7:30 PM
Applied Therapeutics (Issuer)
Chinoporos Constantine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
7:30 PM
Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
7:30 PM
Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
4:28 PM
Applied Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G/A
02/03/2025
2:30 PM
Applied Therapeutics (Subject)
MORGAN STANLEY (Filed by)
Form SCHEDULE 13G/A
01/27/2025
11:48 AM
Applied Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G/A
12/20/2024
7:30 PM
Applied Therapeutics (Issuer)
JOHNSON JOHN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2024
7:30 PM
Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
7:30 PM
Applied Therapeutics (Issuer)
JOHNSON JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
6:07 AM
Applied Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
10:36 AM
Applied Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
12/02/2024
4:15 PM
Applied Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:47 PM
Applied Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
11/14/2024
3:50 PM
Applied Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
11/13/2024
3:15 PM
ALEXANDRIA REAL ESTATE EQUITIES, INC. (Filed by)
Applied Therapeutics (Subject)
Form SC 13G/A
11/08/2024
1:17 PM
Applied Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
11/07/2024
6:30 AM
Applied Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:19 AM
Applied Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:38 PM
Applied Therapeutics (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G
10/31/2024
11:42 AM
Applied Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G/A
10/24/2024
1:02 PM
Applied Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
08/23/2024
3:33 PM
Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:35 PM
Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:52 PM
Applied Therapeutics (Subject)
Shendelman Shoshana (Filed by)
Form SC 13D/A
08/14/2024
6:01 PM
Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
7:43 PM
Applied Therapeutics (Subject)
Shendelman Shoshana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
6:08 AM
Applied Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
6:13 AM
Applied Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/10/2024
3:29 PM
Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump Makes Major Crypto Announcement (Ad)

Trump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.

06/10/2024
3:25 PM
Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:12 PM
Applied Therapeutics (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:13 PM
Applied Therapeutics (Issuer)
SKYLER JAY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:17 PM
Applied Therapeutics (Issuer)
Kanter Stacy J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
5:45 PM
Alexandria Equities No. 7, LLC (Reporting)
ALEXANDRIA REAL ESTATE EQUITIES, INC. (Reporting)
Alexandria Venture Investments, LLC (Reporting)
Applied Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:26 PM
Alexandria Venture Investments, LLC (Reporting)
Applied Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
5:10 PM
Applied Therapeutics (Subject)
Hansard Adam (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2024
6:13 AM
Applied Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:17 AM
Applied Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2024
11:15 PM
Applied Therapeutics (Filer)
Form EFFECT
04/25/2024
3:33 PM
Applied Therapeutics (Filer)
Form 424B3
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:APLT) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners